Lynne Fahey McGrath, Director at Alzamend Neuro, Inc. (ALZN), sold 30 shares at $2.29 ($69) on 2025-10-23, disclosed to the SEC on 2025-10-24.
Open-market sale of $69 ALZN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |